Plasmatic and chamber-specific modulation of cardiac microRNAs in an acute model of DOX-induced cardiotoxicity

Biomedicine & Pharmacotherapy

21 Novembre Nov 2018 19 days ago
  • Gioffré S, Ricci V, Vavassori C, Ruggeri C, Chiesa M, Alfieri I, Zorzan S, Buzzetti M, Milano G, Scopece A, Castiglioni L, Sironi L, Pompilio G, Colombo GI, D'Alessandra Y

Doxorubicin (DOX) is a chemotherapeutic drug limited in its usefulness by an adverse side effect, cardiotoxicity. The mechanisms leading to this detrimental occurrence are not completely clear, and lately many authors focused their attention on the possible role of microRNAs (miRNAs), small regulators of cardiovascular functions, in this phenomenon. Notably, these molecules recently emerged also as potential circulating biomarkers of several cardiac diseases. Thus, the aim of this study was the simultaneous investigation of circulating and cardiac tissue miRNAs expression upon DOX treatment in vivo.

Reference

Gioffré S, Ricci V, Vavassori C, Ruggeri C, Chiesa M, Alfieri I, Zorzan S, Buzzetti M, Milano G, Scopece A, Castiglioni L, Sironi L, Pompilio G, Colombo GI, D'Alessandra Y. Plasmatic and chamber-specific modulation of cardiac microRNAs in an acute model of DOX-induced cardiotoxicity. Biomed Pharmacother 2018 Nov 16;110:1-8. doi: 10.1016/j.biopha.2018.11.042.

Go to PubMed